Amani Therapeutics vs Kite Pharma

Amani Therapeutics vs Kite Pharma, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amani Therapeutics is on 53/100 and Kite Pharma on 66/100.

Amani TherapeuticsDeveloping highly efficacious, safer medicines.
Kite Pharma logo
Kite PharmaBiotechnology company developing and commercializing cell therapies for cancer treatment.
Try Kite Pharma

Where each one leads

Amani Therapeutics

Leads on none of the measures we hold for both companies.

Kite Pharma

  • our overall score: 66/100 against 53/100
  • funding raised: $421M against $25.0M

At a glance

MeasureAmani TherapeuticsKite Pharma
What it isDeveloping highly efficacious, safer medicines.Biotechnology company developing and commercializing cell therapies for cancer treatment.
CategoryBiotechnology, Pharmaceuticals, HealthcareBiotechnology, Pharmaceuticals, Oncology, Cell Therapy
Sells toBusiness modelNot publishedB2B
OfferingServicesServices
FoundedNot published2009
HeadquartersNew York, USASanta Monica, United States
StatusActiveActive

Size, funding and growth

MeasureAmani TherapeuticsKite Pharma
Total funding$25.0M$421M
Latest roundSeries AVenture

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAmani TherapeuticsKite Pharma
StartupHub scoreOur 0-100 rating53/10066/100
Traction37/10040/100
TeamNot published80/100
Search visibility25/10015/100
QualityNot published90/100
Agent readinessHow well an AI agent can read and act on the siteNot publishedF (35/100)
Domain ratingLink authority, 0-100Not published62/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAmani TherapeuticsKite Pharma
CDNNot detectedCloudflare
FrameworksNot detectedTailwind CSS, Bootstrap
AnalyticsNot detectedGoogle Tag Manager

Amani Therapeutics vs Kite Pharma: common questions

Which is better, Amani Therapeutics or Kite Pharma?

On our 0-100 score Kite Pharma rates higher (66/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.

How do Amani Therapeutics and Kite Pharma compare on the numbers?

Kite Pharma leads on our overall score (66/100 against 53/100), funding raised ($421M against $25.0M).

Read the full Amani Therapeutics review and pricing or the Kite Pharma review and pricing. You can also browse other Amani Therapeutics alternatives we track.